Staphylococcus is the most common cause of community- and hospital-acquired infective endocarditis worldwide. Staphylococcal (S. aureus) endocarditis is a serious health problem in children and adults that carries high morbidity and mortality. The incidence of this disease is increasing due to healthcare advances with widespread use of intra-cardiac devices and prosthetic heart valves, and greater prevalence of valvular heart disease. One of the key limitations with antibiotic therapy for S. aureus endocarditis is poor drug penetrationintothevegetation.Theshearjetsinducedbyultrasound-mediatedcavitation(UMC)ofcirculating microbubbles (MBs) have been utilized to dissolve thrombi within vessels and the microvasculature. Fibrin affordsanattractivetargetfordevelopingtargetedMBsinthetreatmentofendocarditiswithultrasound,asthe conjugatebindingpermitsMBadherenceeveninconditionsofhighshearstress.Weproposetodevelopfibrin- targeted MBs, and evaluate the effectiveness of fibrin-targeted MBs and UMC co-administered with systemic vancomycininthetreatmentofS.aureusaorticvalveendocarditis.Afterproductionofbioconjugateandfibrin- targeted MBs, we will evaluate MB binding to the fibrin target under conditions of variable shear stress. We hypothesize that UMC of fibrin targeted MB will improve vancomycin activity against S. aureus by improving antibiotic penetration into the vegetation, and promoting vegetation clearance. Furthermore, we hope to demonstrate that the reductions in vegetation size by UMC may decrease complications including valvular regurgitation, perivalvular extension and embolization, resulting in improved outcomes including survival. We willexaminethistherapeuticapproachinanestablishedrabbitmodelofS.aureusendocarditis,randomizedto receive either transthoracic UMC application with systemic vancomycin co-administered with fibrin-targeted MBs, versus vancomycin alone. Bacterial counts (colony forming units/ml) in the treated vegetation will be quantifiedastheprimaryoutcomevariable.Residualbacterialcountsinperipheralorgansandbrainasaresult of embolic phenomena will also be quantified. Secondary outcomes of serial vegetation size, valvular regurgitation and five-day survival will be tested. Successful completion of this research could significantly impact the clinical management of this life-threatening disease. Results of these studies will be used to advancethisnon-invasivetherapeuticstrategyintoanInvestigationalNewDrugapplication.

Public Health Relevance

Staphylococcal infective endocarditis is increasing in incidence, and becoming more virulent;? andthereforeposesaseriousriskformajormorbidityandmortalityinchildrenandadults.We propose to develop fibrin-targeted microbubbles to assist in getting antibiotics into the vegetation and dissolving it non-invasively, and examine the effectiveness of ultrasound- mediatedcavitationofthesebubblesco-administeredwithsystemicantibioticinthetreatmentof endocarditicvegetations.Ifourresultsdemonstratesuccess,thistreatmentapproachcouldbe usedclinicallyinseriouslyillendocarditispatientstoimprovesurvivalandpreventtheneedfor valvereplacementsurgery.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41HD089823-01
Application #
9202987
Study Section
Special Emphasis Panel (ZRG1-SBIB-T (10)B)
Program Officer
Zajicek, Anne
Project Start
2016-09-01
Project End
2017-08-31
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
1
Fiscal Year
2016
Total Cost
$243,164
Indirect Cost
Name
Nuvox Pharma, LLC
Department
Type
DUNS #
825136141
City
Tucson
State
AZ
Country
United States
Zip Code
85719
Kutty, Shelby; Jones, Philip G; Karels, Quentin et al. (2018) Association of Pediatric Medical Emergency Teams With Hospital Mortality. Circulation 137:38-46